Skip to main content
. Author manuscript; available in PMC: 2021 Jul 16.
Published in final edited form as: Invest Radiol. 2019 May;54(5):257–264. doi: 10.1097/RLI.0000000000000543

Table 2.

Histopathological diagnoses of all lesions.

Malignant lesions n Benign lesions n
Invasive carcinoma NST 53 (81.6%) Fibroadenoma 24 (40.7%)
Invasive lobular carcinoma 6 (9.2%) Fibroadenomatous hyperplasia 8 (13.6%)
Ductal carcinoma in situ 4 (6.2%) Papilloma 5 (8.5%)
Mucinous carcinoma 1 (1.5%) Fibrosis 4 (6.7%)
Neuroendocrine carcinoma 1 (1.5%) Others 18 (30.5%)

NST: no special type.